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Background
The cerebellum is classically considered mainly involved
in motor processing, but recent studies have suggested
several other functions, including pain processing. PET
studies of acute migraine attacks have revealed activa-
tion of the cerebellum. In human pain imaging studies
activation of the cerebellum is almost always observed,
suggesting a role in nociception. Calcitonin gene-related
peptide (CGRP) has been shown to be one of the most
important neuropeptides involved in migraine pathology,
where there is elevated release of CGRP during migraine
attacks and CGRP receptor antagonists have antimi-
graine efficacy.
Methods
In vitro autoradiography mapping studies were per-
formed on human and rhesus monkey. Slices of cerebel-
lum were incubated with [3H]MK-3207 (a CGRP
receptor antagonist) or [125I]CGRP to define the bind-
ing sites. Immunofluorescence was used to study the
detailed distribution of CGRP and its receptor compo-
nents- calcitonin receptor-like receptor (CLR) and
receptor activity modifying protein 1 (RAMP1)- in
human and rhesus monkey cerebellum, using a set of
newly characterized antibodies. In addition, expression
of procalcitonin was studied.
Results
High [3H]MK-3207 binding densities were observed in the
molecular layer of rhesus cerebellum, however due to the
limit of resolution of the autoradiographic image the exact
cellular localization could not be determined. Similarly,
[125I]CGRP binding was observed in the molecular layer
of human cerebellum. Immunofluorescence revealed
expression of CGRP, CLR and RAMP1 in the Purkinje
cells and cells in the molecular layer. Procalcitonin was
also found in Purkinje cells and cells in the molecular
layer.
Conclusions
The study demonstrated CGRP receptor binding sites and
expression of CGRP and its receptor in primate cerebel-
lum, which points toward a functional role of CGRP in
cerebellum. It is also suggests that cerebellum may be a
site of action of CGRP receptor antagonists.
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